The Gillett Health Podcast Sarms & GLP1's
May 2, 2025
GLP-1 medications promise weight loss but raise concerns about long-term health risks. SARMs, like Inobosarm, show potential for boosting bone health and improving mobility, especially in older adults. The conversation explores the ethical landscape of research chemicals and emphasizes the importance of personalized treatment approaches. There's a candid critique of the pharmaceutical industry's approval tactics and the impact of societal expectations on health choices. Also discussed are innovative peptide treatments and the intersection of aesthetics with medical practices.
AI Snips
Chapters
Transcript
Episode notes
Kyle's GLP-1 Aesthetic Motivation
- Kyle Gillett wanted GLP-1 drugs mainly for aesthetic benefits like reducing puffiness and bloating.
- He humorously sought a medical justification, such as dementia risk, to rationalize his use of GLP-1 drugs.
Dose-Dependent GLP-1 Risks
- GLP-1 drugs show dose-dependent side effects with minimal side effects at micro doses.
- Risks like gallbladder and growth hormone elevation exist but benefits can outweigh risks for many people.
Alternatives to GLP-1 for Leanness
- Instead of GLP-1, people might consider adding weightlifting or testosterone for leaner physique.
- Not all facial bloating is bad; hydration and better food choices can affect appearance.